Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.4c03085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Sergio Mallart und 27 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Drug Discovery, Sanofi R&D, 13 quai Jules Guesde, Vitry sur Seine 94400, France. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Relaxin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Sanofi, Association Nationale de la Recherche et de la Technologie.
Abstract (Originalsprache)
Peptide 1, a C18 fatty acid-modified single-chain relaxin analogue, was recently identified as a potent, selective, and long-lasting relaxin family peptide receptor 1 (RXFP1) agonist. Further advanced pharmacokinetic profiling of this compound highlighted elevated levels of oxidative metabolism occurring in dogs and mini pigs but only marginally in rats. This study aimed to design long-lasting relaxin analogues with increased stability against metabolic oxidation while securing subnanomolar RXFP1 potency. Key structural elements, including fatty acid chain length, attachment position, and linker structure, were modified to reduce oxidative metabolism and improve pharmacokinetic parameters. Additionally, incorporating α-methyl lysine (Mly) at position 30, alongside other selective sequence mutations, resulted in several analogues with subnanomolar RXFP1 potency and improved duration of action compared to 1. Compound 21 (R2R01) was then selected as a candidate for an in-depth characterization. It is currently undergoing phase 2 clinical development for renal and cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Integrated Drug Discovery, Sanofi R&D, 13 quai Jules Guesde, Vitry sur Seine 94400, France.
- Peptides and Small Molecules R&D Department, IRBM, Spa, Via Pontina Km 30 600, Pomezia 00071, Italy.
- Department of Translational Biology, IRBM, Spa, Via Pontina Km 30 600, Pomezia 00071, Italy.
- Experimental Pharmacology, IRBM, Spa, Via Pontina Km 30 600, Pomezia 00071, Italy.
- Cardio-Vascular and Metabolism, Sanofi R&D, 13 quai Jules Guesde, Vitry sur Seine 94400, France.
- DMPK France, Sanofi R&D, 13 quai Jules Guesde, Vitry sur Seine 94400, France.
ORCID-Profile: Sergio Mallart, Raffaele Ingenito, Paola Magotti, Alberto Bresciani, Annalise Di Marco, Simone Esposito, Fulvia Caretti, Laura Orsatti, Alessia Santoprete, Daniela Roversi, Federica Tucci, Laurence Gauzy-Lazo, Frank Marguet, Claire Minoletti, Olivier Pasquier, Bruno Poirier, Aurélien Azam, Bernard Maillère, Elisabetta Bianchi, Stephane Illiano
Förderung
- Sanofi
- Association Nationale de la Recherche et de la Technologie
Zitieren
APA
Mallart, S., Ingenito, R., Magotti, P., Bresciani, A., Di Marco, A., Esposito, S., Monteagudo, E., Caretti, F., Orsatti, L., Santoprete, A., Roversi, D., Tucci, F., Veneziano, M., Brasseur, D., Chénedé, X., Corbier, A., Gauzy-Lazo, L., Gervat, V., Marguet, F., …, & Illiano, S. (2025). Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c03085
Vancouver
Mallart S, Ingenito R, Magotti P, Bresciani A, Di Marco A, Esposito S, et al. Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c03085
BibTeX
@article{Mallart2025,
author = {Mallart, Sergio and Ingenito, Raffaele and Magotti, Paola and Bresciani, Alberto and Di Marco, Annalise and Esposito, Simone and Monteagudo, Edith and Caretti, Fulvia and Orsatti, Laura and Santoprete, Alessia and Roversi, Daniela and Tucci, Federica and Veneziano, Maria and Brasseur, Denis and Chénedé, Xavier and Corbier, Alain and Gauzy-Lazo, Laurence and Gervat, Vincent and Marguet, Frank and Minoletti, Claire and Pasquier, Olivier and Poirier, Bruno and Azam, Aurélien and Maillère, Bernard and Bianchi, Elisabetta and Janiak, Philip and Duclos, Olivier and Illiano, Stephane},
title = {Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.4c03085}
}
EUVIMED